Compare PLRX & STKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLRX | STKS |
|---|---|---|
| Founded | 2015 | 2004 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.3M | 74.3M |
| IPO Year | N/A | N/A |
| Metric | PLRX | STKS |
|---|---|---|
| Price | $1.16 | $2.20 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 4 |
| Target Price | $3.75 | ★ $4.38 |
| AVG Volume (30 Days) | ★ 896.1K | 15.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $23.94 |
| Revenue Next Year | N/A | $5.93 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.09 | $1.70 |
| 52 Week High | $3.46 | $5.26 |
| Indicator | PLRX | STKS |
|---|---|---|
| Relative Strength Index (RSI) | 42.47 | 54.59 |
| Support Level | $1.09 | $1.91 |
| Resistance Level | $1.22 | $2.25 |
| Average True Range (ATR) | 0.06 | 0.15 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 29.55 | 81.70 |
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
The One Group Hospitality Inc is a restaurant company that develops, owns and operates, manages and licenses upscale and polished casual, high-energy restaurants and lounges and provides turn-key food and beverage (F&B) services for hospitality venues, including hotels, casinos, and other high-end locations internationally. The company operates through four segments: STK, Benihana and Grill Concepts. The company generates the vast majority of its revenue from the domestic market.